Re: ISMB/ECCB 2023 Keynote Information

Added, thanks!

Seth Munholland, Ph.D., DES

Lead Technologist

International Society for Computational Biology

525-K East Market Street, RM 330

Leesburg, VA, USA 20176

T: (403) 831-2587

On Tue, Jul 4, 2023 at 10:46 AM Steven Leard <steven@marketwhys.ca> wrote:

thanks Mark - Seth will get this added shorty, 

thanks,

Steven

Steven Leard

ISMB Conference Director

steven@marketwhys.ca

On Jul 4, 2023, at 10:45 AM, Mark Gerstein <mark@gersteinlab.org> wrote:

Title:
A Gradual Evolution in Bioinformatics Research

Abstract:
This talk will survey my lab's computational biology research from the
1990s to the present and touch upon the broader directions of the
field. I'll start by discussing some early work on structure and
simulation and how this transitioned into studying protein and gene
networks and, eventually, human genome annotation with
machine-learning models. Finally, I'll discuss some of our current
work developing models for variant impact based on allele-specific
binding and how this highlights the role of transcription-factor
binding motifs that are particularly sensitive to mutation. I'll end
with thoughts on where I think the field is going. In particular, I'll
discuss the importance of dealing with large amounts of private data
and using digital sensors to phenotype individuals more accurately.

==
i0ismb23

Re: ISMB/ECCB 2023 Keynote Information

thanks Mark - Seth will get this added shorty, 

thanks,

Steven

Steven Leard

ISMB Conference Director

steven@marketwhys.ca

On Jul 4, 2023, at 10:45 AM, Mark Gerstein <mark@gersteinlab.org> wrote:

Title:
A Gradual Evolution in Bioinformatics Research

Abstract:
This talk will survey my lab's computational biology research from the
1990s to the present and touch upon the broader directions of the
field. I'll start by discussing some early work on structure and
simulation and how this transitioned into studying protein and gene
networks and, eventually, human genome annotation with
machine-learning models. Finally, I'll discuss some of our current
work developing models for variant impact based on allele-specific
binding and how this highlights the role of transcription-factor
binding motifs that are particularly sensitive to mutation. I'll end
with thoughts on where I think the field is going. In particular, I'll
discuss the importance of dealing with large amounts of private data
and using digital sensors to phenotype individuals more accurately.

==
i0ismb23

Fwd: ISMB/ECCB 2023 Keynote Information

Title:
A Gradual Evolution in Bioinformatics Research

Abstract:
This talk will survey my lab's computational biology research from the
1990s to the present and touch upon the broader directions of the
field. I'll start by discussing some early work on structure and
simulation and how this transitioned into studying protein and gene
networks and, eventually, human genome annotation with
machine-learning models. Finally, I'll discuss some of our current
work developing models for variant impact based on allele-specific
binding and how this highlights the role of transcription-factor
binding motifs that are particularly sensitive to mutation. I'll end
with thoughts on where I think the field is going. In particular, I'll
discuss the importance of dealing with large amounts of private data
and using digital sensors to phenotype individuals more accurately.

==
i0ismb23

Re: The Festival of Genomics and Biodata, October 2023, Boston

Title & Bullets for Festival of Genomics Talk

Personal Functional Genomics

* EN-TEx includes >1500 datasets (>25 tissues X 10 assays) mapped to 4
personal genomes
* Comprehensive catalog of allele-specific activity, decorating
regulatory elements
* Model for transferring known eQTLs to difficult-to-profile tissues
(eg skin=>heart)
* Transformer model for predicting allelic activity based on local
sequence context

i0flg23

Invited Session for JSM 2023

Title: Single Cell Data Analysis: Computational methods for
characterizing cell types

I will describe two techniques for the analysis of single-cell
sequencing data. (1) Forest Fire Clustering. This is an efficient and
interpretable method for cell-type discovery from single-cell data. It
makes minimal prior assumptions and, different from current
approaches, calculates a non-parametric posterior probability that
each cell is assigned a cell-type label. These posterior distributions
allow for the evaluation of a label confidence for each cell and
enable the computation of "label entropies," highlighting transitions
along developmental trajectories. (2) SCAN-ATAC-Sim. It is difficult
to benchmark the performance of various scATAC-seq analysis techniques
(such as clustering and deconvolution) without having a priori a known
set of gold-standard cell types. To simulate scATAC-seq experiments
with known cell-type labels, we introduce an efficient and scalable
scATAC-seq simulation method that down-samples bulk ATAC-seq data
(e.g., from representative cell lines or tissues). Our protocol uses a
consistent but tunable signal-to-noise ratio across cell types in a
scATAC-seq simulation.

SCAN-ATAC-Sim: a scalable and efficient method for simulating
single-cell ATAC-seq data from bulk-tissue experiments.
Z Chen, J Zhang, J Liu, Z Zhang, J Zhu, D Lee, M Xu, M Gerstein
(2021). Bioinformatics 37: 1756-8.

Forest Fire Clustering for single-cell sequencing combines iterative
label propagation with parallelized Monte Carlo simulations.
Z Chen, J Goldwasser, P Tuckman, J Liu, J Zhang, M Gerstein (2022).
Nat Commun 13: 3538.

A new reply has been shared with you on 7/9/2022 11:43:18 a.m.

Hello glabstracts.mbglab



Thanks for your response . As a Research Assistant of the
Research and Development Department working with Cimar Laboratory
Ltd Cambodia, One of the leading Bio-Pharmaceutical Companies
here in Cambodia. I'm looking for a reliable businessman/
individual in your region to represent my company in sourcing
some of our basic raw material used in the manufacturing of high-
quality Anti-Viral Vaccines, Cancer treatment, and other life-
saving Pharmaceutical Products.



This may not be your area of specialization but it will be
another income generating business out of your specialty. This is
because Our company is yet to locate any seller to buy from.
However, I have been able to discover a local dealer who can
supply us with this product. He is selling at a cheap rate, which
is far cheaper than our previous purchases.



My director is not yet aware that I have found a new seller. Now,
THIS IS MY PROPOSAL TO YOU; I want you to stand in as a new local
dealer from your country and I will introduce you to our company.
The reason for this is because I don't want my company to have
direct contact with the local agent that sells this herbal oil
extract very cheaply.



This will enable us to work together as partners and make really
cool profits. You as the local seller will supply our company at
a good rate which I will inform you how to go about it later when
we are in agreement. You will be amazed with what we can achieve
together.

I will give you more specific profit details when I receive
feedback from you if you are interested.



Regards .
Megan Elizabeth
Research Assistant
Research and Development Department
Cimar Laboratory Ltd
Email: elizmegan@mail.ee

visiting McGill on 7/25

Topics in Neurogenomics & Genomic Privacy

Abstract
My talk will focus on neurogenomics and how this has inspired my group
to become interested in privacy and security. I'll first talk about
work in the PsychENCODE consortium and how we have developed tools,
particularly clustering algorithms, related to this area. Then, I'll
talk about how important it is to keep large-scale cohort data,
particularly for mental illness, both private and secure. I'll
highlight some techniques that we have developed for security,
particularly in relation to putting a genome on a blockchain.